|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
CAPNIA, Inc. Announces Appointment of Ernest Mario, Ph.D. as Chairman & CEO
8/6/2007 12:33:44 PM
PALO ALTO, Calif.--(BUSINESS WIRE)--Capnia, Inc. today announced the appointment of Ernest Mario, Ph.D., as the company’s new Chairman and Chief Executive Officer. Dr. Mario joins Capnia from Reliant Pharmaceuticals, where until recently he served as Chairman and Chief Executive Officer.
Dr. Mario has 40 years of experience in the pharmaceutical industry. He began his career in 1966 as a pharmaceutical researcher at Strasenburgh Laboratories in Rochester, NY. He later held various management positions within SmithKline and Squibb, and joined Glaxo PLC in 1986, rising to the position of Chief Executive and Deputy Chairman. During his tenure at Glaxo, Dr. Mario oversaw the launch of five major brands that grew the company's sales and profits by nearly 15 percent annually. In 1993, Dr. Mario became CEO of ALZA Corporation, which was acquired by Johnson & Johnson in 2001 in one of the largest mergers in the pharmaceutical industry.
|
|
|
|
|
|
|
|
|
|
|